Plasminogen (PLG) (N-Term) Peptide
PLG
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5510963
Aperçu rapide pour Plasminogen (PLG) (N-Term) Peptide (ABIN5510963)
Antigène
PLG
(Plasminogen (PLG))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Séquence
- KSSIIIRMRD VVLFEKKVYL SECKTGNGKN YRGTMSKTKN GITCQKWSST
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-PLG Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PLG (Plasminogen (PLG))
-
Sujet
-
The protein encoded by this gene is a secreted blood zymogen that is activated by proteolysis and converted to plasmin and angiostatin. Plasmin dissolves fibrin in blood clots and is an important protease in many other cellular processes while angiostatin inhibits angiogenesis. Defects in this gene are likely a cause of thrombophilia and ligneous conjunctivitis. Two transcript variants encoding different isoforms have been found for this gene.
Protein Size: 810 -
ID gène
- 5340
-
NCBI Accession
- NM_000301, NP_000292
-
UniProt
- P00747
Antigène
-
Vous êtes ici:
